✦ LIBER ✦

411 Metabolic syndrome is correlated with prostatic inflammation in men with severe LUTS related to benign prostatic hyperplasia: Results of a preclinical and clinical experimental study

✍ Scribed by Vignozzi, L.; Gacci, M.; Cellai, I.; Sebastianelli, A.; Salvi, M.; Santi, R.; Morelli, A.; Rastrelli, G.; Comeglio, P.; Maneschi, E.; Corona, G.; Nesi, G.; De, Nunzio C.; Tubaro, A.; Carini, M.; Maggi, M.

Book ID: 122441513
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 99 KB
Volume: 12
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(13)60896-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

119 Metabolic syndrome can be related to

119 Metabolic syndrome can be related to the development of prostatic inflammation in men with benign prostatic hyperplasia

✍ M. Gacci; R. Santi; G. Nesi; A. Sebastianelli; C. Giannessi; S. Giancane; S. Kho 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Relationship Between Predictors of the R

Relationship Between Predictors of the Risk of Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome in Men With Moderate to Severe Lower Urinary Tract Symptoms

✍ Kwon, Hanna; Kang, Hee Cheol; Lee, Jun Ho 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Re: Relationship between Predictors of t

Re: Relationship between Predictors of the Risk of Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome in Men with Moderate to Severe Lower Urinary Tract Symptoms

✍ Kaplan, Steven A. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

Patient-reported outcomes in men with lo

Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study

✍ Emilio Sacco; Riccardo Bientinesi; Francesco Marangi; Angelo Totaro; Alessandro 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB

1383 COMBINATION OF α-ADRENERGIC RECEPTO

1383 COMBINATION OF α-ADRENERGIC RECEPTOR BLOCKERS AND 5 α-REDUCTASE INHIBITORS FOR MODERATE TO SEVERE BENIGN PROSTATE HYPERPLASIA (BPH) PATIENTS WITH OR WITHOUT CONCOMITANT HYPERTENSION: RESULTS OF A PROSPECTIVE OBSERVATIONAL REAL-LIFE CLINICAL PRACTICE STUDY USING MULTICENTER REGISTRIES IN CHINA

✍ Sun, Ying-Hao; Xu, Chuan-Liang; Yang, Bo; Zhou, Tie 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 55 KB